Evidence map›Paper›PMID 37519510›Full record

ReviewCureus2023

Association of Acetaminophen With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Pharmacologic Considerations and Treatment Options.

Noah J Spillers, Patrick M Luther, Norris C Talbot, Gianni H Ly, Evan M Downs, Gabriel Lavespere, Denisa Pavlickova, Shahab Ahmadzadeh, Omar Viswanath, Giustino Varrassi and 2 more

Open access · diamondAbstract readReview
In one paragraph

Review in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Noah J SpillersAnesthesiology, Louisiana State University Health Sciences Center, Shreveport, USA.
Patrick M LutherAnesthesiology, Louisiana State University Health Sciences Center, Shreveport, USA.
Norris C TalbotRadiology, Louisiana State University Health Sciences Center, Shreveport, USA.
Gianni H LyAnesthesiology, Louisiana State University Health Sciences Center, Shreveport, USA.
Evan M DownsAnesthesiology, Louisiana State University Health Sciences Center, Shreveport, USA.
Gabriel LavespereAnesthesiology, Louisiana State University Health Sciences Center, Shreveport, USA.
Denisa PavlickovaAnesthesiology, Louisiana State University Health Sciences Center, Shreveport, USA.
Shahab AhmadzadehAnesthesiology, Louisiana State University Health Sciences Center, Shreveport, USA.
Omar ViswanathPain Management, Valley Pain Consultants - Envision Physician Services, Phoenix, USA.
Giustino VarrassiPain Medicine, Paolo Procacci Foundation, Rome, ITA.
Sahar ShekoohiAnesthesiology, Louisiana State University Health Sciences Center, Shreveport, USA.
Alan D KayeAnesthesiology, Louisiana State University Health Sciences Center, Shreveport, USA.
Pain Management Institute · USFondazione Roma · ITLouisiana State University Health Sciences Center Shreveport · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acetaminophen is an extremely common drug with many implications for its analgesic and antipyretic properties. It has a unique mechanism of action and downstream effects that separate it categorically from non-steroidal anti-inflammatory drugs. These differences come with potential adverse effects that range from mild drug reactions to severe life-threatening emergencies. While acetaminophen's toxic liver effects are well known, a lesser-known adverse effect of this drug is its association with the development of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). These dermatological emergencies involve similar pathological processes, including apoptosis of the epidermis and sloughing of the dermis and mucosa from the underlying layers with a positive Nikolsky sign. Currently, SJS and TEN are considered immune-mediated type IV hypersensitivity reactions predominantly involving CD8+ T lymphocytes. Other immune mediators, including regulatory T cells, natural killer cells, interleukins, and drug metabolites are speculated to be involved, but their mechanisms have not been entirely determined. These conditions are differentially diagnosed by the percentage of body area affected with SJS and TENS, involving <10% and >30%, respectively. Genomic variations in human leukocyte antigens (HLA) genes have been implicated in the susceptibility and severity of acetaminophen-induced SJS/TENS, however, details of these interactions remain unclear. Acetaminophen's widespread use and the morbidity of its associated skin pathologies SJS and TENS warrant an in-depth examination of the causative processes involved in their pathogenesis. It is critical that both physicians and patients be made aware that while acetaminophen is widely tolerated by most individuals, severe and potentially fatal interactions do occur, and further investigation is necessary to reduce these adverse effects.

Indexed as

acetaminophenadverse effectsantipyretic analgesicsstevens-johnson syndrometen

Identifiers

PMID37519510
PMCPMC10382713
OpenAlexW4382724353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.